Catch up with what Optometry Times shared this week:

FDA accepts IND for OK-101 for neuropathic corneal pain

By Emily Kaiser Maharjan, Assistant Managing Editor

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Read here...

UC optometrists strike over “bad-faith” bargaining practices, protest low salaries

By Jordana Joy, Associate Editor

Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.

Read here...

Gaps in vision screening for school-aged children uncovered in study

By Lynda Charters

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

Read here...

Diagnosing and treating Demodex blepharitis

By Amy Nau, OD, Dipl CCLRT; Lynda Charters

Everything, no matter how minute, has a purpose and so that must also be the case for the pesky Demodex mite, the infective parasites that lie between or on the eyelashes in highly sebaceous areas. Some researchers think these parasites may help control bacterial populations through their acidic secretions. However, their waste can cause inflammation and hypersensitivity reactions in affected individuals.

Read here...

ALSTAR study identifies potential functional biomarker for early, intermediate AMD

By Lynda Charters

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Read here...